Navigation Links
Plants could pave the way for new ovarian cancer treatments
Date:8/25/2011

Tropical plants may contain the basis of new and effective treatments for ovarian cancer, according to researchers at the Universities of Strathclyde and Portsmouth.

The scientists are developing a programme for testing plant extracts for the ability to stop cells from ovarian tumours growing. In initial tests, several plant extracts killed the tumour samples, taken from cancer patients.

The extracts are complex mixtures of many different chemicals but ingredients in the plants could be used as starting points for new medicines to tackle the disease. The scientists are now planning further investigation of the most promising compounds.

Ovarian cancer is the fifth most common cancer in women, affecting more than 6,500 in the UK alone each year. It is also one of the most deadly, killing more than 4,000 women in the UK annually, despite survival rates nearly doubling in the past 30 years.

The research is an example of the pioneering work of the Strathclyde Institute of Pharmacy and Biomedical Sciences in developing new medicines for illnesses and conditions including infectious diseases, cancer, heart disease, and schizophrenia. An 8 million fundraising campaign is underway for the Institute's new 36 million building, to expand and enhance its innovative research and education in medicine discovery, development and use.

Alan Harvey, Professor of Pharmacology at Strathclyde Institute of Pharmacy and Biomedical Sciences, said: "Ovarian cancer's inherent danger to women's health is compounded by the fact that it is notoriously difficult to detect. The disease's high death rates urgently need to be dealt with through safe and potent new treatments.

"Our collection of natural plant samples gives us a broad range of possibilities for treatment and we have had good results from many plants. A great many samples have been studied in our collaboration with Portsmouth and a lot of activity has been detected that wouldn't have been picked up in conventional tests.

"The high throughput screening in the method we have used has produced a high return and we are hoping that more tests will bring new treatments a step closer."

Ian Cree, Professor of Histopathology, Pharmacy and Biomedical Sciences at Portsmouth's Institute of Biomedical and Biomolecular Science and Director of the Cancer Laboratory at Queen Alexandra Hospital, said: "This is a first no one has managed to use cells obtained directly from cancers to screen an entire library of plant extracts and we are very excited by the results obtained.

"The key now will be to obtain further funding to produce drugs from those samples showing that they can kill cancer cells.

"It should be remembered that drug development is a very lengthy process and that these results, though exciting, are a long way from being used in patients."


'/>"/>

Contact: Media and Corporate Communications
corporatecomms@strath.ac.uk
44-014-154-84123
University of Strathclyde
Source:Eurekalert

Related medicine news :

1. Wayne State researcher receives NSF award to develop neural implants
2. Elimination of national kidney allocation policy improves minority access to transplants
3. Half-matched transplants widen pool of donors for leukemia and lymphoma
4. Study of phytoremediation benefits of 86 indoor plants published
5. FDA: Breast Implants Basically Safe, But Wont Last a Lifetime
6. Wireless tags give physicians details and condition of orthopedic implants with the wave of a wand
7. Liver-cell transplants show promise in reversing genetic disease affecting liver and lungs
8. Study confirms link between breast implants and rare form of cancer
9. Enhanced cord blood stem cell transplants safe in long-term studies
10. Long-term study shows that kidney transplants are faring better than previously reported
11. EPA Proposes Tougher Air Pollution Rules for Power Plants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... ... A new partnership between Goodwill® and Roadie, Inc. aims to make it ... to couches to dressers and bicycles. Roadie — the national on-the-way delivery network — ... center through February 28th. , “January is an exciting time when resolutions are ...
(Date:1/20/2017)... , ... January 20, 2017 , ... Bionic Sports Nutrition ... walks of life, announced it had a successful January ECRM Trade Show in Hilton ... the United States, which allows it to provide its products to all clients at ...
(Date:1/20/2017)... raton florida (PRWEB) , ... January 20, 2017 , ... ... at the Dana Farber Cancer Institute. For Betsy, the clinical trial has been ... her cancer has not worsened. , Betsy Brauser was diagnosed with ovarian cancer ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... “The Angel”: ... the Lord has set out for each of his children. “The Angel” is the ... School of Music in New York City, and impassioned writer. , When asked of ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Christmas in Suffolk”: a ... author, Sara Seymour, who lives in Lafayette, Indiana where she works in a daycare ... coffees and writes. , Published by Christian Faith Publishing, Sara Seymour’s new book is ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... , Jan. 20, 2017  Today, ... Symposia Conference, "PI3K Pathways in Immunology, Growth ... (NASDAQ: INFI ) presented ... development candidate that selectively inhibits phosphoinositide-3-kinase-gamma (PI3K-gamma). ... to help overcome resistance to checkpoint inhibition ...
(Date:1/20/2017)... CINCINNATI , Jan. 20, 2017 /PRNewswire/ ... has acquired Megadyne Medical Products, Inc., a ... manufactures and markets electrosurgical tools used in ... the intelligence of Ethicon,s* advanced energy devices ... representing a major step forward in Ethicon,s ...
(Date:1/20/2017)... January 20, 2017 ... an Nothilfe   Die internationale humanitäre Stadt soll ... zu schaffen   Seine Hoheit Scheich ... VAE sowie Herrscher von Dubai , ... der Hilfe (International Humanitarian City IHC) zu verdreifachen, um ...
Breaking Medicine Technology: